Kezar Life Sciences (KZR) Assets Average (2021 - 2025)
Kezar Life Sciences (KZR) has disclosed Assets Average for 5 consecutive years, with $87.2 million as the latest value for Q4 2025.
- For Q4 2025, Assets Average fell 43.53% year-over-year to $87.2 million; the TTM value through Dec 2025 reached $87.2 million, down 43.53%, while the annual FY2025 figure was $110.7 million, 39.51% down from the prior year.
- Assets Average hit $87.2 million in Q4 2025 for Kezar Life Sciences, down from $103.4 million in the prior quarter.
- Across five years, Assets Average topped out at $311.1 million in Q3 2022 and bottomed at $87.2 million in Q4 2025.
- Average Assets Average over 5 years is $200.8 million, with a median of $189.5 million recorded in 2024.
- Year-over-year, Assets Average soared 129.99% in 2022 and then plummeted 43.53% in 2025.
- Kezar Life Sciences' Assets Average stood at $174.4 million in 2021, then soared by 73.25% to $302.2 million in 2022, then decreased by 22.14% to $235.3 million in 2023, then crashed by 34.38% to $154.4 million in 2024, then tumbled by 43.53% to $87.2 million in 2025.
- According to Business Quant data, Assets Average over the past three periods came in at $87.2 million, $103.4 million, and $117.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.